Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 21
Filter
Add more filters











Publication year range
1.
Sci Rep ; 11(1): 14565, 2021 07 15.
Article in English | MEDLINE | ID: mdl-34267273

ABSTRACT

This study was aimed at establishing the subcorticals substrates of the cognitive and visceromotor circuits of the A32 and A25 cortices of the medial prefrontal cortex and their projections and interactions with subcortical complexes in the common marmoset monkey (Callithrix jacchus). The study was primarily restricted to the nuclei of the diencephalon and amygdala. The common marmoset is a neotropical primate of the new world, and the absence of telencephalic gyrus favors the mapping of neuronal fibers. The biotinylated dextran amine was employed as an anterograde tracer. There was an evident pattern of rostrocaudal distribution of fibers within the subcortical nuclei, with medial orientation. Considering this distribution, fibers originating from the A25 cortex were found to be more clustered in the diencephalon and amygdala than those originating in the A32 cortex. Most areas of the amygdala received fibers from both cortices. In the diencephalon, all regions received projections from the A32, while the A25 fibers were restricted to the thalamus, hypothalamus, and epithalamus at different densities. Precise deposits of neuronal tracers provided here may significantly contribute to expand our understanding of specific connectivity among the medial prefrontal cortex with limbic regions and diencephalic areas, key elements to the viscerocognitive process.


Subject(s)
Callithrix , Prefrontal Cortex/physiology , Amygdala/physiology , Animals , Biotin/analogs & derivatives , Biotin/pharmacokinetics , Brain Mapping , Dextrans/pharmacokinetics , Female , Hypothalamus/physiology , Male , Neural Pathways/physiology , Prefrontal Cortex/anatomy & histology , Stereotaxic Techniques , Thalamus/physiology
2.
Clin Transl Oncol ; 20(5): 599-606, 2018 May.
Article in English | MEDLINE | ID: mdl-28956266

ABSTRACT

OBJECTIVE: Using RGD10-NGR9 dual-targeting superparamagnetic iron oxide nanoparticles to evaluate their potential value in tumor angiogenesis magnetic resonance imaging (MRI) and the biodistribution in vitro and in vivo. MATERIALS AND METHODS: Dual-targeting RGD10-NGR9 ultrasmall superparamagnetic iron oxide (USPIO) nanoparticles were designed and synthesized in our previous study. In vitro, prussian blue staining and phenanthroline colorimetry were conducted to evaluate binding affinity and adsorption of dual-targeting USPIO nanoparticles to αvß3-integrin/APN positive cells. In vivo, a xenograft mouse tumor model was used to evaluate the potential of the dual-targeting nanoparticles as an MRI contrast agent. After intravenous injection, the contrast-to-noise ratio (CNR) values of MR images obtained were calculated at predetermined time-points. The iron level was detected to access the biodistribution and plasma half-time. RESULTS: In vitro, dual-targeting USPIO nanoparticles bound to proliferating human umbilical vein endothelia cells with high specificity. In vivo, contrast MRI of xenograft mice using dual-targeting nanoparticles demonstrated a significant decrease in signal intensity and a greater increase in CNR than standard MRI and facilitated the imaging of tumor angiogenesis in T2*WI. In terms of biodistribution, dual-targeting USPIO nanoparticles increased to 1.83 times in tumor lesions as compared to the control. And the plasma half-time was about 6.2 h. CONCLUSION: A novel RGD10-NGR9 dual-targeting USPIO has a great potential value as a contrast agent for the identification of tumor angiogenesis on MRI, according to the high specific affinity in vitro and in vivo.


Subject(s)
Contrast Media/pharmacokinetics , Dextrans/pharmacokinetics , Magnetic Resonance Imaging/methods , Neoplasms, Experimental/diagnostic imaging , Neovascularization, Pathologic/diagnostic imaging , A549 Cells , Animals , Dextrans/chemistry , Heterografts , Humans , Magnetite Nanoparticles/chemistry , Mice , Mice, Inbred BALB C , Mice, Nude , Peptides , Tissue Distribution
3.
J Biomed Mater Res B Appl Biomater ; 102(4): 860-8, 2014 May.
Article in English | MEDLINE | ID: mdl-24458920

ABSTRACT

In this research work, DEXTRAN- and polyethylene glycol (PEG)-coated iron-oxide superparamagnetic nanoparticles were synthetized and their cytotoxicity and biodistribution assessed. Well-crystalline hydrophobic Fe3 O4 SPIONs were formed by a thermal decomposition process with d = 18 nm and σ = 2 nm; finally, the character of SPIONs was changed to hydrophilic by a post-synthesis procedure with the functionalization of the SPIONs with PEG or DEXTRAN. The nanoparticles present high saturation magnetization and superparamagnetic behavior at room temperature, and the hydrodynamic diameters of DEXTRAN- and PEG-coated SPIONs were measured as 170 and 120 nm, respectively. PEG- and DEXTRAN-coated SPIONs have a Specific Power Absorption SPA of 320 and 400 W/g, respectively, in an ac magnetic field with amplitude of 13 kA/m and frequency of 256 kHz. In vitro studies using VERO and MDCK cell lineages were performed to study the cytotoxicity and cell uptake of the SPIONs. For both cell lineages, PEG- and DEXTRAN-coated nanoparticles presented high cell viability for concentrations as high as 200 µg/mL. In vivo studies were conducted using BALB/c mice inoculating the SPIONs intravenously and exposing them to the presence of an external magnet located over the tumour. It was observed that the amount of PEG-coated SPIONs in the tumor increased by up to 160% when using the external permanent magnetic as opposed to those animals that were not exposed to the external magnetic field.


Subject(s)
Dextrans/pharmacokinetics , Ferric Compounds/pharmacokinetics , Magnetic Fields , Nanoparticles , Animals , Chlorocebus aethiops , Dextrans/administration & dosage , Dextrans/toxicity , Dogs , Drug Carriers , Drug Evaluation, Preclinical , Female , Ferric Compounds/administration & dosage , Ferric Compounds/toxicity , In Vitro Techniques , Injections, Intravenous , Liver/metabolism , Lung/metabolism , Madin Darby Canine Kidney Cells , Magnetite Nanoparticles/administration & dosage , Magnetite Nanoparticles/toxicity , Mammary Neoplasms, Experimental/metabolism , Materials Testing , Mice , Mice, Inbred BALB C , Nanoparticles/administration & dosage , Nanoparticles/toxicity , Polyethylene Glycols , Skin/metabolism , Spectroscopy, Fourier Transform Infrared , Tissue Distribution , Vero Cells
4.
Braz. j. pharm. sci ; 49(1): 75-83, Jan.-Mar. 2013. graf, tab
Article in English | LILACS | ID: lil-671403

ABSTRACT

A hydrogel was developed from 70 kDa dextran (DEX-70) and praziquantel (PZQ) incorporated as a model drug. Biopharmaceutical properties, such as solubility and dissolution rate, were analysed in the design of the hydrogel. Furthermore, the hydrogel was also characterized by IR spectroscopy and DSC. Tests of the swelling rate showed that the hydrogel swelled slowly, albeit faster than the rate for the free polymer. In dissolution tests, the hydrogel released the drug slowly and continuously. This slow release was similar to that observed in the swelling tests and resulted in controlled release of the drug. Thus, this dextran is a suitable polymer for the development of hydrogels as vehicles for the controlled release of drugs.


Um hidrogel foi desenvolvido a partir de dextrano 70 kDa (DEX-70) e praziquantel incorporado (PZQ) como fármaco modelo. Propriedades biofarmacêuticas, como solubilidade e velocidade de dissolução, foram analisadas no desenvolvimento do hidrogel. Além disso, o hidrogel também foi caracterizado por espectroscopia na região do infravermelho e calorimetria diferencial exploratória (DSC). Testes da taxa de intumescimento mostraram que o hidrogel intumesce lentamente, embora tenha sido mais rápido do que a taxa do polímero livre. Nos testes de dissolução, o hidrogel liberou o fármaco lenta e continuamente. Esta liberação lenta foi semelhante a observada nos testes de intumescimento e resultou em uma liberação controlada do fármaco. Assim, o dextrano 70 kDa é um polímero adequado para o desenvolvimento de hidrogéis como veículos para a liberação controlada de fármacos.


Subject(s)
Praziquantel/pharmacokinetics , Dextrans/pharmacokinetics , Hydrogel, Polyethylene Glycol Dimethacrylate/analysis , Drug Liberation , Biopharmaceutics/classification , Dissolution/classification
5.
J Biomed Nanotechnol ; 8(2): 301-8, 2012 Apr.
Article in English | MEDLINE | ID: mdl-22515081

ABSTRACT

Magnetic resonance is used to investigate biodistribution aspects of dextran-coated magnetite nanoparticles (9.4 nm core diameter) in both liver and spleen from 5 minutes up to 6 months after intravenous administration of a magnetic fluid sample in female Swiss mice. Using magnetic resonance data important parameters such as the absorption half-life (t 1/2 = 12 +/- 2 min in the liver and t 1/2 = 11 +/- 2 min in the spleen), the peak time (1.7 +/- 0.2 h in the liver and 1.9 +/- 0.2 h in the spleen), and the disposition half-life of the dextran-coated magnetite nanoparticles in mice organs (t 1/2 = 70 +/- 10 h in the liver and t 1/2 = 32 +/- 7 h in the spleen) were assessed. In addition, light and electron microscopy showed several aspects that may be related to the iron metabolism. Microscopic analysis also revealed that although magnetite nanoparticles or iron released from them are retained in the organism for a long period of time, no morphologic alteration is induced by the intravenous administration of the magnetic fluid sample, evidencing its biocompatibility. The used tests may represent an adequate methodology for nanotoxicology evaluation.


Subject(s)
Dextrans/pharmacokinetics , Drug Carriers/pharmacokinetics , Magnetite Nanoparticles/chemistry , Animals , Dextrans/chemistry , Drug Carriers/chemistry , Female , Histocytochemistry , Injections, Intravenous , Liver/metabolism , Magnetic Resonance Spectroscopy , Mice , Microscopy, Electron , Models, Animal , Particle Size , Photomicrography , Spleen/metabolism , Tissue Distribution
6.
Nucl Med Biol ; 39(1): 145-53, 2012 Jan.
Article in English | MEDLINE | ID: mdl-22079036

ABSTRACT

INTRODUCTION: The aim of this work was to quantify the effects of injection volume at different technetium-99m specific radiotracer doses on its lymphatic movement in animal model. PROCEDURES: Effects of injection volume (50, 100 µl) at different doses (0.05, 0.135, 0.22 nmol) on popliteal node (PN) detection were studied in rats. The radiotracer under study was (99m)Technetium-cysteine-mannose-dextran conjugate (30 kDa). RESULTS: At 0.05 nmol dose, higher PN uptake was observed at 50 µl injection volume (2.6 fold increase). Conversely, at 0.135 nmol dose, an increase of radiotracer retention in PN was achieved at 100 µl volume, 78% higher than 50 µl. However, at 0.22 nmol dose, the injection volume changes did not influence on the PN uptake. Considering as suitable radiotracer performance: high PN uptake and extraction, better combinations were 0.05 nmol/50 µl, 0.135 nmol/100 µl, 0.22/50 µl. CONCLUSION: Suitable performances could be reached by proper combinations of dose, injection volume and concentration for a specific radiotracer used in sentinel lymph node detection.


Subject(s)
Cysteine/analogs & derivatives , Dextrans/pharmacokinetics , Lymph Nodes/metabolism , Mannose/pharmacokinetics , Organotechnetium Compounds/pharmacokinetics , Radiopharmaceuticals/pharmacokinetics , Animals , Cysteine/administration & dosage , Cysteine/pharmacokinetics , Dextrans/administration & dosage , Female , Lymph Nodes/diagnostic imaging , Mannose/administration & dosage , Organotechnetium Compounds/administration & dosage , Radionuclide Imaging , Radiopharmaceuticals/administration & dosage , Rats , Rats, Wistar , Sentinel Lymph Node Biopsy/methods , Tissue Distribution
7.
Invest Ophthalmol Vis Sci ; 52(12): 8944-50, 2011 Nov 21.
Article in English | MEDLINE | ID: mdl-22003113

ABSTRACT

PURPOSE: Specific proteolytic cleavages of the hormone prolactin (PRL) generate vasoinhibins, a family of peptides (including 16-kDa PRL) that are able to inhibit the pathologic increase in retinal vasopermeability (RVP) associated with diabetes. Here the authors tested the ability of an adenoassociated virus type 2 (AAV2) vasoinhibin vector to inhibit vascular endothelial growth factor (VEGF)- and diabetes-induced RVP. METHODS: AAV2 vectors encoding vasoinhibin, PRL, or soluble VEGF receptor 1 (soluble FMS-like tyrosine kinase-1 [sFlt-1]) were injected intravitreally into the eyes of rats. Four weeks later, either VEGF was injected intravitreally or diabetes was induced with streptozotocin. Tracer accumulation was evaluated as an index of RVP using fluorescein angiography or the Evans blue dye method. RT-PCR verified transgene expression in the retina, and the intravitreal injection of an AAV2 vector encoding green fluorescent protein revealed transduced cells in the retinal ganglion cell layer. In addition, Western blot analysis of AAV2-transduced HEK293 cells confirmed the expression and secretion of the vector-encoded proteins. RESULTS: The AAV2-vasoinhibin vector prevented the increase in tracer accumulation that occurs 24 hours after the intravitreal injection of VEGF. Diabetes induced a significant increase in tracer accumulation compared with nondiabetic controls. This increase was blocked by the AAV2-vasoinhibin vector and reduced by the AAV2-sFlt-1 vector. The AAV2-PRL vector had no effect. CONCLUSIONS: These results show that an AAV2-vasoinhibin vector prevents pathologic RVP and suggest it could have therapeutic value in patients with diabetic retinopathy.


Subject(s)
Capillary Permeability/genetics , Cell Cycle Proteins/genetics , Dependovirus/genetics , Diabetes Mellitus, Experimental/complications , Diabetic Retinopathy/therapy , Genetic Therapy/methods , Albumins/pharmacokinetics , Animals , Capillary Permeability/drug effects , Coloring Agents/pharmacokinetics , Dextrans/pharmacokinetics , Diabetes Mellitus, Experimental/genetics , Diabetic Retinopathy/genetics , Disease Models, Animal , Evans Blue/pharmacokinetics , Fluorescein-5-isothiocyanate/analogs & derivatives , Fluorescein-5-isothiocyanate/pharmacokinetics , Gene Transfer Techniques , Green Fluorescent Proteins/genetics , HEK293 Cells , Humans , Intravitreal Injections , Male , Plasmids/genetics , Rats , Rats, Wistar , Retinal Hemorrhage/chemically induced , Retinal Hemorrhage/genetics , Retinal Hemorrhage/therapy , Vascular Endothelial Growth Factor A/pharmacology
8.
Int J Nanomedicine ; 5: 203-11, 2010 Apr 07.
Article in English | MEDLINE | ID: mdl-20463936

ABSTRACT

The aim of the present work is the presentation of a quantification methodology for the control of the amount of superparamagnetic iron oxide nanoparticles (SPIONs) administered in biological materials by means of the ferromagnetic resonance technique (FMR) applied to studies both in vivo and in vitro. The in vivo study consisted in the analysis of the elimination and biodistribution kinetics of SPIONs after intravenous administration in Wistar rats. The results were corroborated by X-ray fluorescence. For the in vitro study, a quantitative analysis of the concentration of SPIONs bound to the specific AC133 monoclonal antibodies was carried out in order to detect the expression of the antigenic epitopes (CD133) in stem cells from human umbilical cord blood. In both studies FMR has proven to be an efficient technique for the SPIONs quantification per volume unit (in vivo) or per labeled cell (in vitro).


Subject(s)
Contrast Media/pharmacokinetics , Dextrans/pharmacokinetics , Ferrosoferric Oxide/pharmacokinetics , Animals , Magnetics , Magnetite Nanoparticles , Male , Metabolic Clearance Rate , Organ Specificity , Rats , Rats, Wistar , Tissue Distribution
9.
Eur J Pharm Sci ; 38(4): 312-9, 2009 Nov 05.
Article in English | MEDLINE | ID: mdl-19666114

ABSTRACT

The aim of this work is to estimate the excipient percolation threshold for a new combined matrix native dextran (DT), series B110-1-2 (Mw 2 x 10(6)): HPMC K4M CR: lobenzarit disodium (LBD) system and demonstrate the advantages of this ternary system with respect to previously reported binary dextran:LBD and HPMC:LBD tablets. The formulations studied were prepared with different amounts of excipient (DT:HPMC, 4:1 (wt/wt) for all tablets and relative polymer/drug particle size of 4.17) in the range of 10-70% (wt/wt). Dissolution studies were carried out using the paddle method (100 rpm) and one face water uptake measurements were performed using a modified Enslin apparatus. The Higuchi's models as well as the non-linear regression were employed as empiric methods to study the released data. Values of diffusion exponent 0.588

Subject(s)
Dextrans/chemistry , Lactose/analogs & derivatives , Methylcellulose/analogs & derivatives , Technology, Pharmaceutical/methods , ortho-Aminobenzoates/chemistry , Dextrans/pharmacokinetics , Lactose/chemistry , Lactose/pharmacokinetics , Methylcellulose/chemistry , Methylcellulose/pharmacokinetics , Porosity , Tablets , Technology, Pharmaceutical/statistics & numerical data , ortho-Aminobenzoates/pharmacokinetics
10.
J Biotechnol ; 122(3): 326-33, 2006 Apr 10.
Article in English | MEDLINE | ID: mdl-16446004

ABSTRACT

An enzymatic approach, based on a transglutaminase-catalyzed coupling reaction, was investigated to modify bovine liver catalase with an end-group aminated dextran derivative. We demonstrated that catalase activity increased after enzymatic glycosidation and that the conjugate was 3.8-fold more stable to thermal inactivation at 55 degrees C and 2-fold more resistant to proteolytic degradation by trypsin. Moreover, the transglutaminase-mediated modification also improved the pharmacokinetics behavior of catalase, increasing 2.5-fold its plasma half-life time and reducing 3-fold the total clearance after its i.v. administration in rats.


Subject(s)
Catalase/chemistry , Dextrans/chemistry , Transglutaminases/chemistry , Animals , Cadaverine/analogs & derivatives , Cadaverine/chemistry , Catalase/blood , Catalase/pharmacokinetics , Catalysis , Cattle , Dextrans/pharmacokinetics , Diamines/chemistry , Female , Fluorescent Dyes/chemistry , Rats , Rats, Wistar , Streptomyces/enzymology
11.
Acta Radiol ; 47(1): 65-70, 2006 Feb.
Article in English | MEDLINE | ID: mdl-16498935

ABSTRACT

PURPOSE: To study which of the two most used radiopharmaceutical drugs for the sentinel lymph node (SLN) biopsy procedure (dextran 500 99mTc and phytate 99mTc) best defines the SLN and migrates less to other lymph nodes. MATERIAL AND METHODS: Thirty-two rats, separated into two groups, underwent lymphoscintigraphy examination with either dextran or phytate followed by sentinel (popliteal), lumbar, and inguinal lymph node biopsy. Radiation was detected with a gamma probe. RESULTS: The statistical study indicated count rates significantly higher in the SLN than in the other basins for both the dextran (P<0.01) and phytate groups (P<0.001). There was no statistically significant difference concerning SLN absorption in either group (P=0.2981). In the dextran group, migration occurred to 1.5 lymphatic basins with counting higher than 10% of that found in the SLN versus 0.8 in the phytate group (P=0.0023). Migration was thus higher in the dextran group (P=0.0207). CONCLUSION: There was no statistically significant difference between dextran and phytate in the SLN identification, but the phytate migrated to fewer lymphatic basins beyond the SLN and with less intensity.


Subject(s)
Dextrans/administration & dosage , Lymph Nodes/diagnostic imaging , Phytic Acid/administration & dosage , Radiopharmaceuticals/administration & dosage , Sentinel Lymph Node Biopsy/methods , Technetium/administration & dosage , Animals , Dextrans/pharmacokinetics , Male , Phytic Acid/pharmacokinetics , Radionuclide Imaging , Rats , Rats, Wistar , Technetium/pharmacokinetics , Tissue Distribution/physiology
12.
Proc Natl Acad Sci U S A ; 99(1): 495-500, 2002 Jan 08.
Article in English | MEDLINE | ID: mdl-11756680

ABSTRACT

Rat cortical astrocytes in pure culture are functionally coupled to neighboring cells via connexin (Cx) 43 gap junctions under ordinary conditions. Small fluorescent molecules such as Lucifer yellow (LY) pass between cell interiors via gap junctions, but do not enter the cells when externally applied. Subjecting rat and mouse cortical astrocytes to "chemical ischemia" by inhibition of glycolytic and oxidative metabolism induced permeabilization of cells to Lucifer yellow and ethidium bromide before loss of membrane integrity determined by dextran uptake and lactate dehydrogenase release. The gap junction blockers octanol and 18alpha-glycyrrhetinic acid markedly reduced dye uptake, suggesting that uptake was mediated by opening of unapposed hemichannels. Extracellular La(3+) also reduced dye uptake and delayed cell death. The purinergic blocker, oxidized ATP, was ineffective. Astrocytes isolated from mice with targeted deletion of the Cx43 coding DNA exhibited greatly reduced dye coupling and ischemia-induced dye uptake, evidence that dye uptake is mediated by Cx43 hemichannels. Dye coupling was reduced but not blocked by metabolic inhibition. Blockade of lipoxygenases or treatment with free radical scavengers reduced dye uptake by rat astrocytes, suggesting a role for arachidonic acid byproducts in hemichannel opening. Furthermore, permeabilization was accompanied by reduction in ATP levels and dephosphorylation of Cx43. Although hemichannel opening would tend to collapse electrochemical and metabolic gradients across the plasma membrane of dying cells, healthy cells might rescue dying cells by transfer of ions and essential metabolites via Cx43 gap junctions. Alternatively, dying astrocytes might compromise the health of neighboring cells via Cx43 gap junctions, thereby promoting the propagation of cell death.


Subject(s)
Astrocytes/metabolism , Connexin 43/chemistry , Connexin 43/metabolism , Gap Junctions/chemistry , Glycyrrhetinic Acid/analogs & derivatives , Adenosine Triphosphate/metabolism , Animals , Calcium/metabolism , Cells, Cultured , Dextrans/pharmacokinetics , Ethidium/pharmacology , Fluorescent Dyes/pharmacology , Free Radical Scavengers , Gap Junctions/metabolism , Glycyrrhetinic Acid/metabolism , Humans , Intercalating Agents/pharmacology , Ions , Isoquinolines/metabolism , L-Lactate Dehydrogenase/pharmacokinetics , Lanthanum/metabolism , Lipoxygenase Inhibitors/pharmacology , Mice , Protein Binding , Rats , Recombinant Fusion Proteins/metabolism , Time Factors
13.
Am J Physiol Renal Physiol ; 282(1): F45-50, 2002 Jan.
Article in English | MEDLINE | ID: mdl-11739111

ABSTRACT

Plasma albumin restricts capillary water filtration. Accordingly, the glomerular ultrafiltration coefficient is higher in Nagase analbuminemic rats (NAR) than in Sprague-Dawley controls. We investigated whether the glomerular permeability to macromolecules is also enhanced in NAR. SDS-PAGE fractionation of urine proteins showed several bands with molecular masses between 60 and 90 kDa in NAR only. Acute administration of BSA to NAR led to nearly complete disappearance of these proteins from urine, an effect partially reversed when most of the exogenous albumin was cleared from circulation. The fractional clearance of 70-kDa dextran was increased in NAR, indicating a size defect. Binding of cationized ferritin to the glomerular basement membrane was decreased in NAR, suggesting associated depletion of fixed anions. The magnitude of cationic ferritin binding correlated negatively with the fractional clearance of 70-kDa dextran, suggesting that the two abnormalities may share a common pathogenic mechanism. Collectively, these results suggest enhanced glomerular permeability to macromolecules in NAR. Albumin may be necessary to maintain the normal glomerular permselectivity properties.


Subject(s)
Acetylglucosaminidase/genetics , Acetylglucosaminidase/metabolism , Kidney Glomerulus/metabolism , Serum Albumin/deficiency , Animals , Blood Proteins/urine , Capillary Permeability/physiology , Dextrans/pharmacokinetics , Electrophoresis, Polyacrylamide Gel , Ferritins/analysis , Kidney Function Tests , Kidney Glomerulus/chemistry , Kidney Glomerulus/ultrastructure , Macromolecular Substances , Microscopy, Electron , Proteinuria/genetics , Proteinuria/metabolism , Rats , Rats, Mutant Strains , Rats, Sprague-Dawley , Serum Albumin/pharmacokinetics
14.
Nucl Med Commun ; 22(5): 499-504, 2001 May.
Article in English | MEDLINE | ID: mdl-11388570

ABSTRACT

This work was designed to compare sentinel lymph node (SLN) uptake of 99mTc-labelled human serum albumin colloid (99mTc-HSAC), 99mTc-labelled antimony sulphur colloid (99mTc-SC) and a 99mTc-labelled dextran 70 solution (99mTc-Dx) and their selectivity in the identification of this node in the right rear footpad (RRF) of normal mice and tumour bearing mice. Radiopharmaceutical uptake in the SLN (popliteal lymph node) and the lumbar lymph node (LLN), the second lymphatic node station from RRF, were measured at different time points post-intradermal or intratumoural injection into the RRF of NIH normal mice and of Balb/c mice harbouring the murine mammary tumour M2. 99mTc-HSAC uptake in the SLN was significantly higher than LLN uptake. The 99mTc-SC demonstrated high uptake in SLN, but accumulation in LLN was also high. 99mTc-Dx showed low uptakes in both SLN and LLN. The intradermal injection resulted in a more effective radiopharmaceutical accumulation in SLN than did the intratumoural inoculation. Data also show that increments in tumour volume reduced radiopharmaceutical uptake in the SLN. Our results show that 99mTc-HSAC exhibits the highest uptake in the SLN combined with the smallest amounts of radiopharmaceutical passing through to the LLN. Therefore, 99mTc-HSAC appears to be the best radiopharmaceutical for sentinel node detection.


Subject(s)
Adenocarcinoma/diagnostic imaging , Antimony , Dextrans , Lymph Nodes/diagnostic imaging , Lymphatic Metastasis/diagnostic imaging , Mammary Neoplasms, Experimental/diagnostic imaging , Organotechnetium Compounds , Radiopharmaceuticals , Serum Albumin , Technetium Compounds , Adenocarcinoma/pathology , Animals , Antimony/pharmacokinetics , Dextrans/pharmacokinetics , Female , Humans , Mammary Neoplasms, Experimental/pathology , Mice , Mice, Inbred BALB C , Mice, Inbred Strains , Organotechnetium Compounds/pharmacokinetics , Radionuclide Imaging , Radiopharmaceuticals/pharmacokinetics , Reproducibility of Results , Sentinel Lymph Node Biopsy , Serum Albumin/pharmacokinetics , Technetium Compounds/pharmacokinetics , Tissue Distribution
15.
Pflugers Arch ; 439(4): 433-44, 2000 Feb.
Article in English | MEDLINE | ID: mdl-10678739

ABSTRACT

Nuclear envelope (NE) cisternal Ca2+ and cytosolic ATP are required for nuclear-pore-complex-(NPC-) mediated transport of DNAs, RNAs, transcription factors and other large molecules. Isolated cardiomyocyte nuclei, capable of macromolecular transport (MMT), have intrinsic NPC ion channel behavior. The large ion conductance (gamma) activity of the NPC channel (NPCC) is blocked by the NPC monoclonal antibody mAb414, known to block MMT, and is also silenced during periods of MMT. In cardiomyocytes, neither cytosolic Ca2+ nor ATP alone directly affects NPCC gating. To test the role of Ca2+ and ATP in NPCC activity, we carried out the present patch-clamp study with the pipette attached to the outer NE membrane of nuclei isolated from cultured Dunning G prostate cancer cells. Our investigations demonstrate that in these isolated nuclei neither cytosolic Ca2+ nor ATP alone directly affects NPCC gating. However, when simultaneously applied to the bath and pipette, they transiently silence NPCC activity through stimulation of MMT by raising the Ca2+ concentration in the NE cisterna ([Ca2+]NE). Our fluorescence microscopy observations with nuclear-targeted macromolecular fluorochromes (B-phycoerythrin and plasmid for the enhanced green fluorescence protein EGFP, pEGFP-C1) and with FITC-labeled RNA support the view that channel silence accompanies MMT. Repeated Ca2+ loading of the NE with Ca2+ and ATP, after unloading with 1-5 microM inositol 1,4,5-trisphosphate (IP3), thapsigargin (TSG) or 5 mM BAPTA or EGTA, failed to affect channel gating. This result indicates that other factors are involved in this phenomenon and that they are exhausted during the first cycle of NE Ca2+ loading/unloading--in agreement with current theories of NPC-mediated MMT. The results explain how Ca2+ and IP3 waves may convert the NE into an effective Ca2+ barrier and, consequently, affect the regulation of gene activity and expression through their feedback on MMT and NPCC gating. Thus, [Ca2+]NE regulation by intracellular messengers is an effective mechanism for synchronizing gene activity and expression to the cellular rhythm.


Subject(s)
Adenosine Triphosphate/pharmacology , Calcium Channels/metabolism , Calcium/pharmacokinetics , Ion Channel Gating/physiology , Nuclear Envelope/metabolism , Adenosine Triphosphate/metabolism , Animals , Antibodies, Monoclonal/pharmacology , Biological Transport/physiology , Calcium Channels/genetics , Calcium Channels/immunology , Chelating Agents/pharmacology , Cytosol/metabolism , Dextrans/pharmacokinetics , Egtazic Acid/analogs & derivatives , Egtazic Acid/pharmacology , Endoplasmic Reticulum/metabolism , Enzyme Inhibitors/pharmacology , Fluorescein-5-isothiocyanate/pharmacokinetics , Fluorescent Dyes/pharmacokinetics , Gene Expression Regulation, Neoplastic , Inositol 1,4,5-Trisphosphate/pharmacology , Ion Channel Gating/drug effects , Male , Nuclear Envelope/chemistry , Oocytes/physiology , Patch-Clamp Techniques , Prostatic Neoplasms , Thapsigargin/pharmacology , Tumor Cells, Cultured , Xenopus laevis
16.
Dev Neurosci ; 22(1-2): 34-43, 2000.
Article in English | MEDLINE | ID: mdl-10657696

ABSTRACT

We have studied gap junctional communication in the anterior subventricular zone (SVZa) of postnatal rodents, revealed by intercellular diffusion of dyes in brain slices. Extensive intercellular dye spread was evident in the SVZa. Coupling was not uniform, being characteristically larger in the outer borders of this layer, overlapping the previously described peripheral zone of concentration of S-phase cells. Intercellular spread of the dye was unaffected by acidification, but totally blocked by high Ca(2+) concentrations. In addition, application of some known uncoupling agents as carbenoxolone and halothane led to a marked reduction of dye spread in the SVZa. Our results demonstrate the presence of dye coupling mediated by gap junctions in the SVZa. Furthermore, the spatial organization of dye coupling in these slices strongly suggests the existence of cell compartments in the postnatal SVZa.


Subject(s)
Animals, Newborn/physiology , Cerebral Ventricles/physiology , Gap Junctions/physiology , Animals , Calcium/metabolism , Carbenoxolone/pharmacology , Dextrans/antagonists & inhibitors , Dextrans/pharmacokinetics , Diffusion/drug effects , Fluorescent Dyes/pharmacokinetics , Halothane/pharmacology , In Vitro Techniques , Intracellular Membranes/metabolism , Isoquinolines/antagonists & inhibitors , Isoquinolines/pharmacokinetics , Mice , Rats , Rats, Wistar , Rhodamines/antagonists & inhibitors , Rhodamines/pharmacokinetics , Uncoupling Agents/pharmacology
17.
J Cell Sci ; 112 ( Pt 5): 681-93, 1999 Mar.
Article in English | MEDLINE | ID: mdl-9973603

ABSTRACT

The intracellular parasite Leishmania survives and proliferates in host macrophages. In this study we show that parasitophorous vacuoles of L. mexicana gain access to cytosolic material via two different routes. (1) Small anionic molecules such as Lucifer Yellow are rapidly transported into the vacuoles by an active transport mechanism that is sensitive to inhibitors of the host cell's organic anion transporter. (2) Larger molecules such as fluorescent dextrans introduced into the host cell cytosol are also delivered to parasitophorous vacuoles. This transport is slower and sensitive to modulators of autophagy. Infected macrophages were examined by two novel assays to visualize and quantify this process. Immunoelectron microscopy of cells loaded with digoxigenin-dextran revealed label in multivesicular endosomes, which appeared to fuse with parasitophorous vacuoles. The inner membranes of the multivesicular vesicles label strongly with antibodies against lysobisphosphatidic acid, suggesting that they represent a point of confluence between the endosomal and autophagosomal pathways. Although the rate of autophagous transfer was comparable in infected and uninfected cells, infected cells retained hydrolyzed cysteine proteinase substrate to a greater degree. These data suggest that L. mexicana-containing vacuoles have access to potential nutrients in the host cell cytosol via at least two independent mechanisms.


Subject(s)
Leishmania mexicana/metabolism , Leishmania mexicana/ultrastructure , Macrophages/parasitology , Vacuoles/metabolism , Adenine/analogs & derivatives , Adenine/pharmacology , Animals , Autophagy , Biological Transport, Active/drug effects , Cysteine Endopeptidases/metabolism , Cytosol/metabolism , Dextrans/pharmacokinetics , Female , In Vitro Techniques , Isoquinolines/pharmacokinetics , Leishmania mexicana/pathogenicity , Macromolecular Substances , Macrophages/metabolism , Mice , Mice, Inbred BALB C , Microscopy, Immunoelectron , Vacuoles/ultrastructure
18.
Metabolism ; 46(12 Suppl 1): 26-30, 1997 Dec.
Article in English | MEDLINE | ID: mdl-9439555

ABSTRACT

The hamster cheek pouch is an experimental model in which quantitative studies of macromolecular permeability can be made by direct observation of extravasated fluorescein isothiocyanate (FITC)-dextran (leaks). The advantage of this model is that simultaneous light and fluorescent-light microscopy observations can be performed with instantaneous correlations between the site of FITC-dextran extravasation and the vessel morphology. The aims of our study were to compare, using the cheek pouch preparation, the effects of two sulfonylureas, gliclazide and glibenclamide, on the macromolecular permeability increase induced by histamine using control (normoglycemic) hamsters. In these studies, FITC-labeled dextran 150,000 daltons was administered intravenously and quantified by UV-light microscopy, and the drugs used were applied topically at therapeutic concentrations. Gliclazide and glibenclamide dose-dependently decreased the macromolecular permeability increase induced by histamine. This effect of gliclazide could be blocked by nifedipine (Ca2+ channel blocker) and not by diazoxide (K+ channel opener), whereas for glibenclamide it could be blocked by diazoxide and not by nifedipine. To better characterize the antioxidant capacity of gliclazide and glibenclamide, their effect on the macromolecular permeability increase induced by ischemia/reperfusion was also compared with the effect of vitamin C in diabetic hamsters (glycemia > 240 mg/dL). Total ischemia of the preparation was obtained with a cuff placed around the neck of the everted pouch. Diabetes was induced by three intraperitoneal injections of streptozotocin 50 mg/kg/d in 3 days. In diabetic hamsters during ischemia/reperfusion, gliclazide was more effective in inhibiting the macromolecular permeability increase than glibenclamide (136.0 +/- 5.8 leaks/cm2 for placebo; 68.0 +/- 2.9 for 1.2 x 10(-6) mol/L gliclazide; 55.3 +/- 3.5 for 1.2 x 10(-5) mol/L gliclazide; 89.2 +/- 5.7 for 8 x 10(-8) mol/L glibenclamide; 107.0 +/- 3.8 for 8 x 10(-7) mol/L glibenclamide; 56.7 +/- 3.4 for 10(-6) mol/L vitamin C; and 20.5 +/- 0.6 for 10(-5) mol/L vitamin C). Our results suggest that (1) the inhibition of the permeability increase induced by histamine elicited by gliclazide may be mediated by Ca2+ channels, while that of glibenclamide may be mediated by K+ channels, and (2) gliclazide appears to have an antioxidant capacity in ischemia/reperfusion injury similar to that of 10(-6) mol/L vitamin C. Improvement in the microcirculation was independent of the hypoglycemic properties of the drug.


Subject(s)
Capillary Permeability/drug effects , Diabetes Mellitus, Experimental/physiopathology , Hypoglycemic Agents/pharmacology , Sulfonylurea Compounds/pharmacology , Animals , Calcium Channel Blockers/pharmacology , Calcium Channels/drug effects , Calcium Channels/physiology , Capillary Permeability/physiology , Cricetinae , Dextrans/pharmacokinetics , Diabetes Mellitus, Experimental/blood , Diazoxide/pharmacology , Disease Models, Animal , Dose-Response Relationship, Drug , Fluorescein-5-isothiocyanate/analogs & derivatives , Fluorescein-5-isothiocyanate/pharmacokinetics , Gliclazide/pharmacology , Glyburide/pharmacology , Histamine/pharmacology , Insulin/blood , Macromolecular Substances , Male , Mesocricetus , Nifedipine/pharmacology , Potassium Channels/drug effects , Potassium Channels/physiology , Reperfusion Injury/metabolism , Reperfusion Injury/physiopathology , Streptozocin
19.
J Hepatol ; 25(3): 329-33, 1996 Sep.
Article in English | MEDLINE | ID: mdl-8895012

ABSTRACT

BACKGROUND/AIM: Dextran-70 is frequently used as a plasma expander in patients with cirrhosis treated with large-volume paracentesis to prevent post-paracentesis hypovolemia, which is thought to develop after 24 h following the procedure. However, there are no studies on Dextran-70 pharmacokinetics in cirrhosis. METHODS: Nine patients with alcoholic cirrhosis and tense ascites treated with a 5-1 paracentesis were given 500 ml of Dextran-70. Blood samples to measure the plasma concentration of dextran were obtained 15 and 30 min, 1, 2, 3, 6, 12 and 24 h and 2 and 6 days after the end of the infusion. Nine healthy volunteers were studied in identical fashion after infusion of 100 ml of Dextran-70. The plasma concentration of dextran was determined by the anthrone method. A bicompartmental model was used to analyze the pharmacokinetic parameters. RESULTS: There were no significant differences between patients with cirrhosis and controls in the volume of distribution (7.7 +/- 0.6 vs. 7.3 +/- 1.21), half-life of the first and second component of plasma disappearance (2.96 +/- 0.69 and 80.3 5.9 h in patients with cirrhosis vs 2.82 +/- 0.69 and 67.1 +/- 10.7 h in controls). CONCLUSIONS: The pharmacokinetics of Dextran-70 in patients with cirrhosis and ascites after large-volume paracentesis is similar to that in controls. This may explain why Dextran-70 is less effective than albumin in preventing paracentesis-induced hypovolemia, which starts after most Dextran fraction has disappeared from plasma.


Subject(s)
Ascites/metabolism , Ascites/therapy , Dextrans/pharmacokinetics , Liver Cirrhosis/metabolism , Liver Cirrhosis/therapy , Paracentesis , Ascitic Fluid/metabolism , Dextrans/blood , Half-Life , Humans , Male , Middle Aged , Osmolar Concentration , Reference Values
20.
J Membr Biol ; 148(3): 233-42, 1995 Dec.
Article in English | MEDLINE | ID: mdl-8747555

ABSTRACT

Lumen to bath J12/C1 and bath to lumen J21/C2 fluxes per unit concentration of 19 probes with diameters (dm) ranging from 3.0-30.0 A (water, urea, erythritol, mannitol, sucrose, raffinose and 13 dextrans with dm 9.1-30.0 A) were measured during volume secretion (Jv) in the upper segment of the Malpighian Tubule of Rhodnius by perfusing lumen and bath with 14C or 3H-labeled probes. Jnet = (J12/C1-J21/C2) was studied as a function of Jv.Jv was varied by using different concentrations of 5-hydroxy tryptamine. Jnet for 3H-water was not different from Jv. We found: (i) A strong correlation between Jnet and Jv for 8 probes dm = 3.0-11.8 A (group a probes), indicating that the convective component of Jnet is more important than its diffusive component and than unstirred layers effects which are negligible. Therefore group a probes are solvent dragged as they cross the epithelium. (ii) There is no correlation between Jnet and Jv for 11 probes with dm = 11.8-30 A (group b). Therefore these probes must cross the epithelium by diffusion and not by solvent drag. (iii) In a plot of Jnet/Jv vs. dm group a probes show a steep linear relation with a slope = -0.111, while for group b probes the slope is -0.002. Thus there is a break between groups a and b in this plot. We tried to fit the data with models for restricted diffusion and convention through cylindrical or parallel slit pathways. We conclude that (i) group a probes are dragged by water through an 11.0 A-wide slit. (ii) Most of Jv must follow an extracellular noncytosolic pathway. (iii) Group b probes must diffuse through a 42 A-wide slit. (iv) A cylindrical pathway does not fit the data.


Subject(s)
Body Water/metabolism , Malpighian Tubules/metabolism , Rhodnius/physiology , Animals , Dextrans/pharmacokinetics , Larva , Models, Biological , Perfusion , Rhodnius/growth & development , Sucrose/pharmacokinetics , Sugar Alcohols/pharmacokinetics , Urea/pharmacokinetics
SELECTION OF CITATIONS
SEARCH DETAIL